Pramipexole Dihydrochloride
- Product NDC
- 68151-3966
- 11-digit product format
- 681513966
- Labeler code
- 68151
- Product ID
- 68151-3966_9c2ab9df-2bd7-43d2-a86b-715ca8c826ab
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pramipexole Dihydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Carilion Materials Management
- Application
- ANDA090865
- Marketing category
- ANDA
- Marketing start
- 2010-10-08
- Marketing end
- 0000-00-00
- Substance
- PRAMIPEXOLE DIHYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 68151-3966 | I | Inactivated by FDA | 2026-08-03 | ||
| excluded package | package | 68151-3966 | 68151-3966-9 | I | Inactivated by FDA | 2026-08-03 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | I | Inactivated by FDA | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | I | Inactivated by FDA | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | I | Inactivated by FDA | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | I | Inactivated by FDA | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | I | Inactivated by FDA | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | I | Inactivated by FDA | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | I | Inactivated by FDA | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | I | Inactivated by FDA | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | I | Inactivated by FDA | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | 1332a3947898… | d4bfe170f9cd… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 68151-3966-9 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded product | product | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… | |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 68151-3966-9 | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090865-001 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | AB | 2010-10-08 | |
| A090865-002 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | AB | 2010-10-08 | |
| A090865-003 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | AB | 2010-10-08 | |
| A090865-004 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 0.75MG | TABLET / ORAL | AB | 2010-10-08 | |
| A090865-005 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | AB | 2010-10-08 | |
| A090865-006 | PRAMIPEXOLE DIHYDROCHLORIDE | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | AB | 2010-10-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090865-001 | AB |
| A090865-002 | AB |
| A090865-003 | AB |
| A090865-004 | AB |
| A090865-005 | AB |
| A090865-006 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A090865-001 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | AB | 2010-10-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090865-002 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | AB | 2010-10-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090865-003 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | AB | 2010-10-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090865-004 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.75MG | TABLET / ORAL | AB | 2010-10-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090865-005 | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | AB | 2010-10-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A090865-006 | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | AB | 2010-10-08 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090865-001 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | AB | 2010-10-08 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090865-002 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | AB | 2010-10-08 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090865-003 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | AB | 2010-10-08 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090865-004 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.75MG | TABLET / ORAL | AB | 2010-10-08 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090865-005 | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | AB | 2010-10-08 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090865-006 | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | AB | 2010-10-08 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090865-001 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | AB | 2010-10-08 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090865-002 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | AB | 2010-10-08 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090865-003 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | AB | 2010-10-08 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090865-004 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.75MG | TABLET / ORAL | AB | 2010-10-08 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090865-005 | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | AB | 2010-10-08 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A090865-006 | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | AB | 2010-10-08 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090865-001 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | AB | 2010-10-08 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090865-002 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | AB | 2010-10-08 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090865-003 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | AB | 2010-10-08 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090865-004 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.75MG | TABLET / ORAL | AB | 2010-10-08 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090865-005 | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | AB | 2010-10-08 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090865-006 | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | AB | 2010-10-08 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090865-001 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | AB | 2010-10-08 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090865-002 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | AB | 2010-10-08 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090865-003 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | AB | 2010-10-08 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090865-004 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.75MG | TABLET / ORAL | AB | 2010-10-08 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090865-005 | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | AB | 2010-10-08 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090865-006 | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | AB | 2010-10-08 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090865-001 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | AB | 2010-10-08 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090865-002 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | AB | 2010-10-08 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090865-003 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | AB | 2010-10-08 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090865-004 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.75MG | TABLET / ORAL | AB | 2010-10-08 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090865-005 | PRAMIPEXOLE DIHYDROCHLORIDE | 1MG | TABLET / ORAL | AB | 2010-10-08 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090865-006 | PRAMIPEXOLE DIHYDROCHLORIDE | 1.5MG | TABLET / ORAL | AB | 2010-10-08 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090865-001 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.125MG | TABLET / ORAL | AB | 2010-10-08 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090865-002 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.25MG | TABLET / ORAL | AB | 2010-10-08 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090865-003 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.5MG | TABLET / ORAL | AB | 2010-10-08 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090865-004 | PRAMIPEXOLE DIHYDROCHLORIDE | 0.75MG | TABLET / ORAL | AB | 2010-10-08 | 2680178bc6a6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A090865-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090865-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090865-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090865-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090865-005 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A090865-006 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090865-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090865-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090865-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090865-004 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090865-005 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A090865-006 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A090865-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090865-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090865-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090865-004 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090865-005 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A090865-006 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090865-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090865-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090865-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090865-004 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090865-005 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A090865-006 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090865-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090865-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090865-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090865-004 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090865-005 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A090865-006 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090865-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090865-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090865-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090865-004 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090865-005 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A090865-006 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090865-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090865-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090865-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A090865-004 | AB | 1 | 2680178bc6a6… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a67b8488-0225-64b1-be81-5cbe60d285a5 | Product name | 9 | 20221116 |
| a62a50ac-1535-4461-9768-8ae703e2e9fb | Product name | 1 | 20210525 |
| 3863aae0-7028-3427-389e-3f6c8692e587 | Product name | 3 | 20190117 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
| bc07ef78-e82d-0c19-31f4-31f263780582 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68151-3966-9 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-fcd0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use Pramipexole Dihydrochloride Tablets safely and effectively. See full prescribing information for pramipexole dihydrochloride tablets. PRAMIPEXOLE dihydrochloride tablets, for oral use Initial U.S. Approval: 1997 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68151-3966-9 | Pramipexole Dihydrochloride | 1 in 1 PACKAGE | TABLET | 1 | 3 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PRAMIPEXOLE DIHYDROCHLORIDE | ACTIVE INGREDIENT | 3D867NP06J | PRAMIPEXOLE DIHYDROCHLORIDE TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| PRAMIPEXOLE | ACTIVE MOIETY | 83619PEU5T | PRAMIPEXOLE DIHYDROCHLORIDE TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | PRAMIPEXOLE DIHYDROCHLORIDE TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | PRAMIPEXOLE DIHYDROCHLORIDE TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| POVIDONE K30 | INACTIVE INGREDIENT | U725QWY32X | PRAMIPEXOLE DIHYDROCHLORIDE TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | PRAMIPEXOLE DIHYDROCHLORIDE TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | PRAMIPEXOLE DIHYDROCHLORIDE TABLET [CARILION MATERIALS MANAGEMENT] | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68151-3966 | PRAMIPEXOLE DIHYDROCHLORIDE TABLET [CARILION MATERIALS MANAGEMENT] | 3 | Legacy NDC, 1 package rows | 20160806_1a31f05c-9b05-4701-a49f-ecc0c75dcd5e.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pramipexole Dihydrochloride | PRAMIPEXOLE DIHYDROCHLORIDE | Bryant Ranch Prepack | 46f88017-7b0e-437e-90b1-37bdf9013e72 | 2026-05-22 | Warnings, Adverse reactions | 090865 ANDA090865 |
| Pramipexole Dihydrochloride | PRAMIPEXOLE DIHYDROCHLORIDE | A-S Medication Solutions | 3db0613d-524b-4b33-9a07-602f84d6c304 | 2026-04-26 | Warnings, Adverse reactions | 090865 ANDA090865 |
| Pramipexole Dihydrochloride | PRAMIPEXOLE DIHYDROCHLORIDE | Bryant Ranch Prepack | bd0f7ae1-11ef-4fab-894f-c4c59f75aa99 | 2026-04-03 | Warnings, Adverse reactions | 090865 ANDA090865 |
| Pramipexole Dihydrochloride | PRAMIPEXOLE DIHYDROCHLORIDE | Bryant Ranch Prepack | dd4b4e2a-97b5-417d-bb90-bec692dc359b | 2026-04-02 | Warnings, Adverse reactions | 090865 ANDA090865 |
| Pramipexole Dihydrochloride | PRAMIPEXOLE DIHYDROCHLORIDE | Torrent Pharmaceuticals Limited | 60167d7c-469f-455a-a113-561841af5e59 | 2026-03-31 | Warnings, Adverse reactions | 090865 ANDA090865 |
| Pramipexole Dihydrochloride | PRAMIPEXOLE DIHYDROCHLORIDE | American Health Packaging | f4d97c2e-f447-4cfe-b9d4-852323f0cfb5 | 2026-03-03 | Warnings, Adverse reactions | 090865 ANDA090865 |
| Pramipexole Dihydrochloride | PRAMIPEXOLE DIHYDROCHLORIDE | Major Pharmaceuticals | 978c0e89-35f0-44a2-9302-8bed7e5d60e0 | 2026-01-21 | Warnings, Adverse reactions | 090865 ANDA090865 |
| Pramipexole Dihydrochloride | PRAMIPEXOLE DIHYDROCHLORIDE | Bryant Ranch Prepack | 794fdab8-1c15-4469-963e-4f9e3495536f | 2025-11-17 | Warnings, Adverse reactions | 090865 ANDA090865 |
| Pramipexole Dihydrochloride | PRAMIPEXOLE DIHYDROCHLORIDE | Bryant Ranch Prepack | 350a3f84-0f98-405f-bdae-6abbc47d48a4 | 2024-08-29 | Warnings, Adverse reactions | 090865 ANDA090865 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 859048 | pramipexole dihydrochloride 1.5 MG Oral Tablet | PSN | 1a31f05c-9b05-4701-a49f-ecc0c75dcd5e | 3 |
| 859048 | pramipexole dihydrochloride 1.5 MG Oral Tablet | SCD | 1a31f05c-9b05-4701-a49f-ecc0c75dcd5e | 3 |
| 859048 | pramipexole dihydrochloride 1.5 MG (equivalent to pramipexole 1 MG) Oral Tablet | SY | 1a31f05c-9b05-4701-a49f-ecc0c75dcd5e | 3 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 68151-3966-9 | 68151396609 | 1 in 1 PACKAGE | Historical |